Ra Medical Systems’ DABRA Atherectomy System Launched in Northern Europe

April 12, 2017

Ra Medical Systems, a maker of excimer lasers and catheters for cardiovascular diseases as well as dermatological diseases, and Bo Medical Technologies, a multinational medical device sales and service distributor, recently announced the launch of the DABRA atherectomy system in Europe. In October 2016, Ra Medical announced that the DABRA system received European CE Mark approval. It is an investigational device in the United States and has a 95% success rate in clinical trials in North America, noted the companies.

About Ra Medical Systems
Ra Medical Systems was founded in 2002 to commercialize excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its flagship product, Pharos, launched in 2004 and revolutionized the dermatology world with its technology and game-changing business model.

Today, Ra Medical Systems continues to make history as it commercializes the DABRA catheter and laser cardiovascular system.